These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36633810)

  • 1. A Mixed-Methods Study to Better Measure Patient-Reported Pain and Fatigue in Soft Tissue Sarcoma.
    Barrett L; Elliott E; Voorhaar M; Ingelgård A; Griebsch I; Wong B; Mills J; Heinrich P; Cano S
    Oncol Ther; 2023 Mar; 11(1):129-143. PubMed ID: 36633810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed-methods research to support the use of new lymphoma-specific patient-reported symptom measures derived from the EORTC item library.
    Markowitz JT; Mazerolle F; Lovell T; Hess LM; Abada PB; Regnault A; Payakachat N
    J Patient Rep Outcomes; 2024 Jan; 8(1):8. PubMed ID: 38252198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus.
    Morel T; Cano S; Bartlett SJ; Gordon C; Haier B; Regnault A; Schneider M; Stach C; Cleanthous S
    Rheumatology (Oxford); 2022 Aug; 61(8):3329-3340. PubMed ID: 34897375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative study to characterize patient experience and relevance of patient-reported outcome measures for patients with metastatic synovial sarcoma.
    Eliason L; Grant L; Francis A; Cardellino A; Culver K; Chawla SP; Arbuckle R; Pokras S
    J Patient Rep Outcomes; 2022 May; 6(1):43. PubMed ID: 35507231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30.
    Regnault A; Pompilus F; Ciesluk A; Mazerolle F; Bejar R; Fram RJ; Faller DV; Marquis P; Bell JA
    J Patient Rep Outcomes; 2021 Jul; 5(1):60. PubMed ID: 34283303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia.
    Bell JA; Galaznik A; Pompilus F; Strzok S; Bejar R; Scipione F; Fram RJ; Faller DV; Cano S; Marquis P
    J Patient Rep Outcomes; 2019 Jun; 3(1):35. PubMed ID: 31218454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric Analysis from EMBODY1 and 2 Clinical Trials to Help Select Suitable Fatigue PRO Scales for Future Systemic Lupus Erythematosus Studies.
    Cleanthous S; Bongardt S; Marquis P; Stach C; Cano S; Morel T
    Rheumatol Ther; 2021 Sep; 8(3):1287-1301. PubMed ID: 34244970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the Myasthenia Gravis (MG) Symptoms PRO: a case study of a patient-centred outcome measure in rare disease.
    Cleanthous S; Mork AC; Regnault A; Cano S; Kaminski HJ; Morel T
    Orphanet J Rare Dis; 2021 Oct; 16(1):457. PubMed ID: 34717694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a Qualitative Study to Develop a Patient Reported Outcome Measure for Patients with 4 Subtypes of Soft Tissue Sarcoma.
    Skalicky AM; Ghate SR; Perez JR; Rentz AM
    Sarcoma; 2017; 2017():6868030. PubMed ID: 28588396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) measure, a patient-reported outcome measure.
    Brod M; Blum SI; Bushnell DM; Ramasamy A
    Qual Life Res; 2015 Dec; 24(12):3001-14. PubMed ID: 26068732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Preliminary Validation of an Instrument to Measure Symptoms and Impacts in Patients with Proliferative Diabetic Retinopathy.
    Rofail D; Sherman S; Hartford C; Levine A; Baldasaro J; Marquis P; Rao R; Do DV
    Adv Ther; 2023 Apr; 40(4):1773-1786. PubMed ID: 36848017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative and psychometric approaches to evaluate the PROMIS pain interference and sleep disturbance item banks for use in patients with rheumatoid arthritis.
    Becker B; Raymond K; Hawkes C; Foster AM; Lovley A; Saucier C; Rizio AA; Bjorner JB; Kosinski M
    J Patient Rep Outcomes; 2021 Jul; 5(1):52. PubMed ID: 34228217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial.
    Vaccarino AL; Kalali AH; Blier P; Gilbert Evans S; Engelhardt N; Foster JA; Frey BN; Greist JH; Kobak KA; Lam RW; MacQueen G; Milev R; Müller DJ; Parikh SV; Placenza FM; Rizvi SJ; Rotzinger S; Sheehan DV; Sills T; Soares CN; Turecki G; Uher R; Williams JBW; Kennedy SH; Evans KR
    Innov Clin Neurosci; 2020 Jul; 17(7-9):30-40. PubMed ID: 33520402
    [No Abstract]   [Full Text] [Related]  

  • 14. Does palliative chemotherapy really palliate and are we measuring it correctly? A mixed methods longitudinal study of health related quality of life in advanced soft tissue sarcoma.
    Gough N; Koffman J; Ross JR; Riley J; Judson I
    PLoS One; 2019; 14(9):e0210731. PubMed ID: 31557183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PROMIS FatigueFM Profile: a self-report measure of fatigue for use in fibromyalgia.
    Kratz AL; Schilling S; Goesling J; Williams DA
    Qual Life Res; 2016 Jul; 25(7):1803-13. PubMed ID: 26821919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the PROFAD-SSI-SF in Patients with Primary Sjögren's Syndrome with Organ Involvement: Results of Qualitative Interviews and Psychometric Analyses.
    Raymond K; Maher S; Saucier CD; O'Connor M; Yarlas A; Kosinski M; Chen WH; Gairy K
    Rheumatol Ther; 2023 Feb; 10(1):95-115. PubMed ID: 36227531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidimensional daily diary of fatigue-fibromyalgia-17 items (MDF-fibro-17). part 1: development and content validity.
    Morris S; Li Y; Smith JAM; Dube' S; Burbridge C; Symonds T
    BMC Musculoskelet Disord; 2017 May; 18(1):195. PubMed ID: 28511678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of a patient reported outcome measure for fatigue and breathlessness for patients with chronic heart failure (OxFAB).
    Walthall H; Strickland LH; Jenkinson C
    Heart Lung; 2023; 58():116-124. PubMed ID: 36493523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance.
    Holloway L; Humphrey L; Heron L; Pilling C; Kitchen H; Højbjerre L; Strandberg-Larsen M; Hansen BB
    Health Qual Life Outcomes; 2014 Jul; 12():116. PubMed ID: 25048687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring the Patient Experience in Rare Disorders: Benefit of Pragmatic Mixed-Methods Research in NUT Carcinoma.
    Ciesluk A; Voorhaar M; Barrett L; Baldasaro J; Griebsch I; Marquis P
    Oncol Ther; 2022 Jun; 10(1):263-277. PubMed ID: 35301699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.